These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 29676584)
1. Current practice of ototoxicity management across the United Kingdom (UK). Maru D; Malky GA Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584 [TBL] [Abstract][Full Text] [Related]
2. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology. Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238 [TBL] [Abstract][Full Text] [Related]
3. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. Konrad-Martin D; Poling GL; Garinis AC; Ortiz CE; Hopper J; O'Connell Bennett K; Dille MF Int J Audiol; 2018 Sep; 57(sup4):S3-S18. PubMed ID: 29157038 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making. King KA; Brewer CC Int J Audiol; 2018 Sep; 57(sup4):S89-S98. PubMed ID: 29276851 [TBL] [Abstract][Full Text] [Related]
5. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy. Brown ECM; Caimino C; Benton CL; Baguley DM J Laryngol Otol; 2021 Jan; 135(1):14-20. PubMed ID: 33487183 [TBL] [Abstract][Full Text] [Related]
6. Audiologists' perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey. Konrad-Martin D; Polaski R; DeBacker JR; Theodoroff SM; Garinis A; Lacey C; Johansson K; Mannino R; Milnes T; Hungerford M; Clark KD J Cancer Surviv; 2023 Feb; 17(1):69-81. PubMed ID: 36729345 [TBL] [Abstract][Full Text] [Related]
7. Contralateral acoustic hearing aid use in adult unilateral cochlear implant recipients: Current provision, practice, and clinical experience in the UK. Fielden CA; Kitterick PT Cochlear Implants Int; 2016 May; 17(3):132-45. PubMed ID: 27078521 [TBL] [Abstract][Full Text] [Related]
8. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program. Paken J; Govender CD; Sewram V BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931 [TBL] [Abstract][Full Text] [Related]
9. The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey. Nikiphorou E; Galloway J; van Riel P; Yazici Y; Haugeberg G; Ostor A; Gogus F; Kauppi M; Sokka T; Clin Exp Rheumatol; 2017; 35(3):477-483. PubMed ID: 28134086 [TBL] [Abstract][Full Text] [Related]
10. Ototoxicity monitoring in children treated with platinum chemotherapy. Brooks B; Knight K Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048 [TBL] [Abstract][Full Text] [Related]
11. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context? Khoza-Shangase K; Masondo N Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290287 [TBL] [Abstract][Full Text] [Related]
12. Ototoxicity: A review of South African studies. Moodley S; Storbeck C; Gama N S Afr Fam Pract (2004); 2021 Mar; 63(1):e1-e10. PubMed ID: 33764142 [TBL] [Abstract][Full Text] [Related]
13. A survey of speech-language therapy provision for people with post-stroke dysarthria in the UK. Miller N; Bloch S Int J Lang Commun Disord; 2017 Nov; 52(6):800-815. PubMed ID: 28620998 [TBL] [Abstract][Full Text] [Related]
15. A national survey of pediatric otolaryngologists and early hearing detection and intervention programs. Danhauer JL; Johnson CE; Finnegan D; Lamb M; Lopez IP; Meuel C; Pecile A; Williams V; Gavin RB; Karns SR; Latiolais LN J Am Acad Audiol; 2006; 17(10):708-21. PubMed ID: 17153719 [TBL] [Abstract][Full Text] [Related]
16. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series. Hollander C; Joubert K; Schellack N JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14036. PubMed ID: 31934875 [TBL] [Abstract][Full Text] [Related]
17. The current state of ototoxicity monitoring in New Zealand. Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864 [TBL] [Abstract][Full Text] [Related]
18. Safety of audiology direct access for medicare patients complaining of impaired hearing. Zapala DA; Stamper GC; Shelfer JS; Walker DA; Karatayli-Ozgursoy S; Ozgursoy OB; Hawkins DB J Am Acad Audiol; 2010 Jun; 21(6):365-79. PubMed ID: 20701834 [TBL] [Abstract][Full Text] [Related]
19. Managing comorbid cognitive impairment and hearing loss in older adults: a UK survey of audiology and memory services. Omar R; Kuo L; Costafreda SG; Hall A; Forbes M; O'Brien JT; Schilder AGM Age Ageing; 2023 May; 52(5):. PubMed ID: 37247401 [TBL] [Abstract][Full Text] [Related]
20. Survey of Current Practice in the Fitting and Fine-Tuning of Common Signal-Processing Features in Hearing Aids for Adults. Anderson MC; Arehart KH; Souza PE J Am Acad Audiol; 2018 Feb; 29(2):118-124. PubMed ID: 29401059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]